miR-124-3p functions as a tumor suppressor in breast cancer by targeting CBL
2016 · BMC Cancer · 107 citations
https://doi.org/10.1186/s12885-016-2862-4
H
Hongwei Liang
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
143
Papers
4.0K
Citations
39
h-index
75
i10-index
Hongwei Liang is an academic researcher from China Pharmaceutical University. The author has contributed to research in topics: MicroRNA in disease regulation & Cancer-related molecular mechanisms research & RNA modifications and cancer. The author has an h-index of 39, co-authored 122 publications.
Papers by this author
worksA Combination of Let-7d, Let-7g and Let-7i Serves as a Stable Reference for Normalization of Serum microRNAs
2013 · PLoS ONE · 105 citations
https://doi.org/10.1371/journal.pone.0079652
miR-23a/b promote tumor growth and suppress apoptosis by targeting PDCD4 in gastric cancer
2017 · Cell Death and Disease · 82 citations
https://doi.org/10.1038/cddis.2017.447
The identification of novel targets of miR-16 and characterization of their biological functions in cancer cells
2013 · Molecular Cancer · 59 citations
https://doi.org/10.1186/1476-4598-12-92
microRNA-141 inhibits cell proliferation and invasion and promotes apoptosis by targeting hepatocyte nuclear factor-3β in hepatocellular carcinoma cells
2014 · BMC Cancer · 57 citations
https://doi.org/10.1186/1471-2407-14-879
miR-203 enhances let-7 biogenesis by targeting LIN28B to suppress tumor growth in lung cancer
2017 · Scientific Reports · 41 citations
https://doi.org/10.1038/srep42680
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat